Open‑access findings you can read and share. Designed for clinicians, investors, and families.
BMC Medicine (2023) — Open Access
Synthesis of 100+ studies: clinically supervised low‑carb/ketogenic approaches reduce body weight, HbA1c, and triglycerides. Emphasizes individualized planning and monitoring.
Frontiers in Nutrition (2023) — Open Access
Benefits for type 2 diabetes, obesity, and neurological conditions; notes LDL may rise in some individuals—supporting routine lipid monitoring and fat‑quality guidance.
Nature Scientific Reports (2024) — Open Access
U.S. population analysis suggests low‑carb adherence is associated with lower overall mortality risk. Observational—supports potential long‑term benefit while acknowledging limitations.
Academy of Nutrition & Dietetics — Open Toolkit
Team‑based workflows for screening, assessment, intervention, and discharge planning. Ready‑to‑use measures to embed nutrition care across hospitals, rehab, and long‑term care.
Clinical Nutrition (2023) — Open Access
Prospective human data show broad metabolomic shifts under ketogenic nutrition—supporting biomarker‑guided personalization and adherence monitoring in real‑world settings.
Clinically validated, cost‑effective, and scalable — evidence shows low‑carb nutrition not only improves metabolic health but reduces long‑term healthcare spending through fewer medications, hospitalizations, and complications.
In a 2‑year diabetes study, ketogenic participants cut outpatient spending by $286 per patient per month and prescription costs by $105 per month, mainly from deprescribing insulin and oral diabetes drugs.
Source: Virta Health 2‑Year Outcomes Study (PMC10987085)
Carbohydrate restriction improves insulin sensitivity, triglycerides, and blood sugar — reducing long‑term costs tied to diabetes, heart disease, and metabolic syndrome management.
Umbrella Review: BMC Medicine (2023)
Participants in structured low‑carb programs average 15% body‑weight loss at 1 year with fewer hunger rebounds — preventing costly relapses and hospital visits related to obesity‑driven complications.
Frontiers in Nutrition, 2025 (TOWARD Study)
Stable blood sugar and ketone metabolism improve energy, cognition, and focus — helping seniors maintain independence and reducing assisted‑care intensity needs over time.
Cambridge University Review (2024)
Average $1,700 annual savings per patient in medication deprescriptions, versus $13,000/year for GLP‑1 drugs — demonstrating that lifestyle‑based care delivers lasting ROI.
Frontiers in Nutrition (2025)